Submissions

Jurnal Ilmiah Farmasi Simplisia (JIFS) welcomes original manuscripts that fall within the journal’s focus and scope. Before submitting a manuscript, authors are required to read the Author Guidelines, complete the Submission Preparation Checklist, and ensure compliance with the journal’s publication ethics and copyright policies. Authors can submit a new manuscript through the online submission system or access their existing submissions to check their status and respond to editorial requests.

Make a new submission or view your pending submissions.

Submission Preparation Checklist

As part of the submission process, authors are required to confirm that their submission complies with all the following requirements. Submissions that do not meet these requirements may be returned to the authors for correction before editorial assessment.

  • ✔The manuscript is original, has not been published previously, and is not under consideration for publication in another journal.
  • ✔The manuscript has been prepared using the official Jurnal Ilmiah Farmasi Simplisia (JIFS) article template and complies with the journal’s Author Guidelines.
  • ✔The submission file is in Microsoft Word (.doc or .docx) or Rich Text Format (.rtf).
  • ✔All authors have approved the submitted version and agree to its submission to JIFS.
  • ✔All sources have been appropriately cited and acknowledged, and the manuscript does not contain plagiarism, data fabrication, data falsification, or other forms of publication misconduct.
  • ✔The manuscript has been checked for similarity, and any overlapping text has been appropriately cited or revised.
  • ✔All tables and figures are numbered, titled, cited in the text, and provided in an appropriate format.Where available, DOI links or URLs have been provided for the references.
  • ✔All applicable research ethics requirements have been fulfilled, and ethical approval and informed consent statements have been included where required.
  • ✔Funding sources, conflicts of interest, author contributions, and other required declarations have been disclosed, as applicable.
  • ✔The authors have read and agreed to comply with JIFS’s publication ethics, copyright and licensing policies, including its separate policy on the use of artificial intelligence (AI).

Author Guidelines

Authors submitting manuscripts to Jurnal Ilmiah Farmasi Simplisia (JIFS) must ensure that their submissions comply with the following requirements.

  1. Originality and Exclusivity
    Manuscripts must be original, must not have been published previously, and must not be under consideration by another journal. Any related publications, preprints, conference papers, or overlapping manuscripts must be disclosed to the editor where applicable.
  2. Manuscript Preparation
    Manuscripts must be prepared using the official JIFS article template and submitted in Microsoft Word (.doc or .docx) or Rich Text Format (.rtf). Authors must follow the journal’s requirements for article structure, language, formatting, references, tables, figures, and supplementary materials.
  3. References and Citations
    All sources cited in the text must appear in the reference list, and all references must be cited in the manuscript. Authors should provide DOI links or URLs whenever available and ensure that references are accurate, relevant, and appropriately up to date.
  4. Authorship and Author Approval
    All listed authors must have made a meaningful scholarly contribution to the work, approved the final manuscript, and agreed to its submission to JIFS. Changes to authorship after submission require editorial approval and agreement from the relevant authors.
  5. Research Ethics and Integrity
    Research involving human participants, animals, identifiable personal information, or other ethically regulated activities must comply with applicable ethical standards and institutional requirements. Ethical approval, approval numbers, and informed consent statements must be provided where applicable. Authors must not engage in plagiarism, duplicate publication, data fabrication, data falsification, or other forms of research or publication misconduct.
  6. Plagiarism Screening
    Submitted manuscripts may be screened using plagiarism-detection software before peer review. Similarity reports are assessed by the editorial team in context; the similarity percentage alone does not determine whether plagiarism has occurred. Manuscripts containing substantial unattributed overlap or other evidence of plagiarism may be returned, rejected, or handled in accordance with the journal’s Publication Ethics policy.
  7. Declarations
    Authors must disclose relevant funding sources, conflicts of interest, author contributions, and data availability information where applicable or required by the journal. Any acknowledgments and permissions for reproduced material must also be provided.
  8. Use of Artificial Intelligence
    Authors must comply with the separate JIFS policy on the use of artificial intelligence (AI) in manuscript preparation and research. AI tools must not be listed as authors, and authors remain responsible for the accuracy, originality, integrity, and appropriate attribution of all submitted content.
  9. Peer Review and Editorial Assessment
    Submissions undergo an initial editorial assessment for scope, completeness, and compliance with the journal’s requirements. Manuscripts considered suitable may be sent for peer review by qualified reviewers. Submission does not guarantee acceptance, and the final publication decision rests with the editor.
  10. Copyright and Licensing
    Authors must read and agree to the journal’s Copyright Notice and licensing terms before publication. The applicable copyright and license conditions are described in the journal’s Copyright Notice.

Submissions that do not meet the journal’s requirements may be returned to the authors for correction before further consideration.

Original Research

This section publishes original research articles that contribute to the advancement of pharmaceutical sciences and related fields. The journal welcomes scientifically sound and methodologically rigorous studies within the following areas:

  • Pharmaceutical Technology: Drug formulation, drug delivery systems, pharmaceutical processing, quality control, and physicochemical characterization of dosage forms.
  • Community Pharmacy: Pharmaceutical care, patient adherence, and the role of pharmacists in community settings.
  • Cosmetics and Cosmeceuticals: Formulation, characterization, safety, efficacy, and regulatory aspects of cosmetic and cosmeceutical products, particularly those derived from natural resources.
  • Clinical Pharmacy: Pharmacotherapy, clinical outcomes, drug utilization, medication safety, and evidence-based clinical practices.
  • Traditional Medicine: Natural products, herbal medicines, ethnopharmacology, and phytochemical studies, including the evaluation of efficacy, safety, and mechanisms of action.
  • Molecular Docking and Computational Studies: In silico research supporting drug discovery, drug–target interactions, and pharmacological mechanisms of bioactive compounds, preferably supported by experimental validation.

JIFS encourages interdisciplinary research integrating experimental and computational approaches to address current challenges in pharmaceutical sciences and contribute to the development of safe and effective therapeutic products.

Submitted manuscripts must present a clear research objective, appropriate methodology, scientifically sound results, and conclusions supported by the findings. All submissions undergo an initial editorial assessment and, where considered suitable, are sent for peer review. Publication decisions are based on the manuscript’s originality, scientific quality, relevance to the journal’s scope, and compliance with publication ethics.

Make a new submission to the Original Research section.

Copyright Notice

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

All articles published Open Access will be immediately and permanently free for everyone to read and download. We are continuously working with our author communities to select the best choice of license:

• Creative Commons Attribution (CC BY)

Privacy Statement

The names, email addresses, affiliations, and other personal information entered into the Jurnal Ilmiah Farmasi Simplisia (JIFS) website will be used exclusively for the purposes of journal administration, manuscript submission, editorial assessment, peer review, publication, and communication related to the journal.

Such information will not be made available for other purposes or disclosed to unrelated third parties without appropriate authorization, except where required by applicable law or necessary for the journal’s legitimate publishing operations.

JIFS takes reasonable measures to protect personal information and maintain the confidentiality of manuscript-related communications. Users are responsible for ensuring that the information they provide is accurate and up to date.